Yinzhi Lang

Research Asst. Professor

University of Florida

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Yinzhi Lang is a Research Assistant Professor at the University of Florida, USA. His research focuses on pharmacokinetics and the treatment of multidrug-resistant bacteria, particularly in relation to Klebsiella pneumoniae and Pseudomonas aeruginosa . Recent publications include studies on the efficacy of various dosage regimens of piperacillin-tazobactam and tobramycin, as well as novel methodologies for targeting bacterial cell wall synthesis.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Jürgen Bulitta

Professor and Perry E. Foote Eminent Scholar Chair

University of Florida

UNITED STATES

View details

Jessica Tait

MONASH UNIVERSITY

AUSTRALIA

View details

Eunjeong Shin

Case Western Reserve University

UNITED STATES

View details

Nicholas Smith

Assistant Professor

University at Buffalo

UNITED STATES

View details

Miranda J. Wallace

Washington University in St. Louis

UNITED STATES

View details

Deanna Deveson Lucas

MONASH UNIVERSITY

AUSTRALIA

View details

John Boyce

MONASH UNIVERSITY

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yinzhi Lang

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model

Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model

Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity

Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling

Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling

Combating Multidrug‐Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational Modeling

Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing <i>Klebsiella pneumoniae</i>.

Generating genotype-specific aminoglycoside combinations with ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae

Combating Multidrug-Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational Modeling

Comparison of Different Labeling Techniques for the LC-MS Profiling of Human Milk Oligosaccharides

Collaborators (7)

Jürgen Bulitta

Jessica Tait

Eunjeong Shin

Nicholas Smith

Miranda J. Wallace

Deanna Deveson Lucas

John Boyce

Make your next move.